time gap between amyloid- and tau-pet positivity in preclinical disease
Published 11 months ago • 166 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
9:01
longitudinal clinical outcomes of tau-pet-positive individuals
-
1:45
promise of tau-pet imaging for alzheimer's disease
-
1:56
advantages of tau-pet compared to amyloid-pet
-
3:53
why does tau-pet not detect the earliest stages of alzheimer’s disease?
-
6:32
the role of tau in autosomal dominant alzheimer’s disease
-
2:19
early predictive value of plasma biomarkers for amyloid positivity
-
1:08
why alzheimer’s disease research is focusing on tau
-
3:11
targeting β-amyloid and tau in alzheimer's disease
-
0:51
current and future role of tau-pet in dementia daily practice
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
2:02
tau pet imaging: the current landscape
-
2:46
value of p-tau231 in early alzheimer’s disease
-
38:18
amyloid pet brain imaging
-
1:21:04
webinar: steven dekosky - alzheimer's: introduction to disease pathology and treatments
-
25:56
it takes two to tango: the importance of amyloid and tau in cognitive decline
-
0:54
reaction of amyloid-β and tau in alzheimer's disease
-
2:03
investigating the relationship of tau and amyloid in alzheimer’s disease
-
1:56
blood p-tau in symptomatic and non-symptomatic ad patients
-
1:00:07
medicine grand rounds: alzheimer's biomarkers and emerging disease-modifying therapeutics 3/21/23